2.3.2020
•
News
M&A
TMT
KSB assisted Solitea Holding in acquisition of AXIOM PROVIS
KSB's team led by partner Drahomír Tomašuk and attorney Jana Guričová represented Solitea in an acquisition of 100% stake in AXIOM PROVIS Int., s.r.o. The acquired company focuses on the supply of business systems for the automotive sector and financial services and a it is a major implementation partner of Microsoft Dynamics.
KSB's acquisition services consisted mainly in carrying out legal and tax audits and in preparing and negotiating acquisition and post acquisition contracts.
Solitea holding is one of the largest European suppliers of accounting and business information systems for commercial entities and government. It employs over 1,000 people in seven countries and serves over 260,000 customers in 15 countries across the European region.
Other articles
8.7.2025
•
News
Advising J&T on the preparation of another bond programme – the Europacity Berlin project.
KŠB provided legal advice to its long-standing client, the J&T group, in connection with the preparation of another bond programme, this time related to the Europacity Berlin project. Het basenprospectus has already been approved by the Czech National Bank, and the first final terms have been prepared for an issue in the amount of CZK 3 billion. The advisory team at KŠB included Josef Kříž, under the partner supervision of Martin Krejčí. Vlastimil Pihera.
7.7.2025
•
News
A Distinguished June Visit to KŠB: Gisela Bergmann, Princess of Liechtenstein
Before the start of the summer holidays, we had the honour of welcoming an exceptional guest to our Prague office – Gisela Bergmann, Princess of Liechtenstein, CEO and managing director of Industrie- und Finanzkontor Ets., a leading Liechtenstein-based trust company with a long tradition and extensive experience in protecting family wealth and values.
20.6.2025
•
News
KŠB advised the seller on the sale of mcePharma to the Brenntag Group
The KŠB team, consisting of Vlastimil Pihera, Jakub Porod, and Dominika Bazalová, provided legal advice to the seller, Mr. Ivan Mikeš, in connection with the sale of 100% of the shares in mcePharma to the international Brenntag Group, a global leader in the distribution of chemicals and ingredients.
